{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-29T12:21:14.996275+00:00",
  "news": [
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxORjVqc3Y2VWFFZ3VOZy1rbDBMUzhWcHY0WDNuRGt6aVBxQlRBM01fcjhlRHVqdjFKc3BERUxMVzFIdFVMWHJxV1diLWhTN0JPdjVuSlRhSkx2eWQ0VC1ZSjhmZlMwX0ozU0g5OXNpZFRIWkJ6TWZIbXNtTnZrNVZKTVAzU0piMDQ2SThHQjN4UWd5YXhr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxORjVqc3Y2VWFFZ3VOZy1rbDBMUzhWcHY0WDNuRGt6aVBxQlRBM01fcjhlRHVqdjFKc3BERUxMVzFIdFVMWHJxV1diLWhTN0JPdjVuSlRhSkx2eWQ0VC1ZSjhmZlMwX0ozU0g5OXNpZFRIWkJ6TWZIbXNtTnZrNVZKTVAzU0piMDQ2SThHQjN4UWd5YXhr?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-27T11:31:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Where Will Vertex Pharmaceuticals Be in 5 Years - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNVHl3QTg2akdOOGxDN1ZsT2FtYkswUFZKQjZIVTJqeEN0X3IwR09scGFkdlNKYk45anF5V29uNTlDLUNudnVTV1ZtV0ZpQWtiVUFqRWZudVFQa05nUjAxVUVweXRGTlpYRDNMY01PQm5IUkQwS214cXQ5Q1RKZGlxR3puVG9RU2Y1QkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNVHl3QTg2akdOOGxDN1ZsT2FtYkswUFZKQjZIVTJqeEN0X3IwR09scGFkdlNKYk45anF5V29uNTlDLUNudnVTV1ZtV0ZpQWtiVUFqRWZudVFQa05nUjAxVUVweXRGTlpYRDNMY01PQm5IUkQwS214cXQ5Q1RKZGlxR3puVG9RU2Y1QkE?oc=5\" target=\"_blank\">Where Will Vertex Pharmaceuticals Be in 5 Years</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-27T11:31:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "What Do Analysts Think About Vertex Pharmaceuticals (VRTX)? - Finviz",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQNmNkZl9zeWdweEpNTjhvMFVVQ3RQV3FaRWRYNEtmVXBEc1BjS2o2dUg4Z3lFNGtEYlNUUkg2bHBlTW13SmdxV2FrNXI2VTNnaElTa0xTVk0zckctVHFjaUxFRXcyd25yYURBWmlNTWxhSUtqS3BnYXd1Z2EtajRZd2dfVS1iNWhhTjdhMkJvZE8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxQNmNkZl9zeWdweEpNTjhvMFVVQ3RQV3FaRWRYNEtmVXBEc1BjS2o2dUg4Z3lFNGtEYlNUUkg2bHBlTW13SmdxV2FrNXI2VTNnaElTa0xTVk0zckctVHFjaUxFRXcyd25yYURBWmlNTWxhSUtqS3BnYXd1Z2EtajRZd2dfVS1iNWhhTjdhMkJvZE8?oc=5\" target=\"_blank\">What Do Analysts Think About Vertex Pharmaceuticals (VRTX)?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Finviz</font>",
      "published": "2025-11-26T21:13:54+00:00",
      "source": "Finviz"
    },
    {
      "title": "Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq? - Barchart.com",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxObm52WjRCZDVNMXdGdVMwbktJVjduSFNqQzF5TWltQWtqdDZnQVlKX0xoRHZtR1ZMcld2YVlqb21BSlFXWEE0aGFtQ204QjFoUHR0d3dOTjh0YzlibmxfLXZacHRHQ1hfelY4MVU4b1NtWjdnNWQzclluSHJNam1KXzh1SmsyMDdXWGJsTHhqNnBsb3UwdzNzMjlERVZQemZvb3J2RmF3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxObm52WjRCZDVNMXdGdVMwbktJVjduSFNqQzF5TWltQWtqdDZnQVlKX0xoRHZtR1ZMcld2YVlqb21BSlFXWEE0aGFtQ204QjFoUHR0d3dOTjh0YzlibmxfLXZacHRHQ1hfelY4MVU4b1NtWjdnNWQzclluSHJNam1KXzh1SmsyMDdXWGJsTHhqNnBsb3UwdzNzMjlERVZQemZvb3J2RmF3?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barchart.com</font>",
      "published": "2025-11-28T11:25:04+00:00",
      "source": "Barchart.com"
    },
    {
      "title": "Vertex Pharmaceuticals: A Diversification Play Poised to Join the Top 10 Global Healthcare Giants - NAI500",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxObUVzNEdUTVFJOHUyc1prVnE5Y0h6WEExYTVoREJjSFU3dDI0NkUwWW5XRVlUcVBlamZiTjJpbmhOaXNqcFNRTUZueWRqVmMtNFFQMnZ5SGhJeTNkQkljRHFLYkpXc1hqSERlaVA2SUZNUVBFbjNfa205MFVtdDhwYW9jY2htZ2ZWWWdGNENLNXMyWTRoQTlnbGphb1B2di1iVDdZV3l4ZVVyMmxram1BSXIyRU4yVkQ4Z2ZhNXpnWGtDRThHeFFucQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxObUVzNEdUTVFJOHUyc1prVnE5Y0h6WEExYTVoREJjSFU3dDI0NkUwWW5XRVlUcVBlamZiTjJpbmhOaXNqcFNRTUZueWRqVmMtNFFQMnZ5SGhJeTNkQkljRHFLYkpXc1hqSERlaVA2SUZNUVBFbjNfa205MFVtdDhwYW9jY2htZ2ZWWWdGNENLNXMyWTRoQTlnbGphb1B2di1iVDdZV3l4ZVVyMmxram1BSXIyRU4yVkQ4Z2ZhNXpnWGtDRThHeFFucQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Diversification Play Poised to Join the Top 10 Global Healthcare Giants</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NAI500</font>",
      "published": "2025-11-28T05:15:49+00:00",
      "source": "NAI500"
    },
    {
      "title": "A Look at Vertex Pharmaceuticals’s Valuation After Discontinuing Experimental Pain Drug Development - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Vertex Pharmaceuticals’s Valuation After Discontinuing Experimental Pain Drug Development</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-26T04:46:35+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "ToolGen sues Vertex in US, expanding CRISPR patent licensing dispute - IAM Patent",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQbUdZVUlQdEhoYzdvT3RFdk1QMUVNenJ4ZkNXNHhwX0FqTUNsbk12SXhoeDBnUEN2cXdDT1N6M1BfUWVqREo3VUxnOGRsTGhOdk45aDFleVBtNjl1SG1wSUlzZHhZeUEyWG5NRHZXSmRXZzRQOXJGRWNYQ3g5VlBkZFctQ2I5eFQwSEJyMExFYTNtYkV2VXZiLVFkWGJkS3hoelB3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxQbUdZVUlQdEhoYzdvT3RFdk1QMUVNenJ4ZkNXNHhwX0FqTUNsbk12SXhoeDBnUEN2cXdDT1N6M1BfUWVqREo3VUxnOGRsTGhOdk45aDFleVBtNjl1SG1wSUlzZHhZeUEyWG5NRHZXSmRXZzRQOXJGRWNYQ3g5VlBkZFctQ2I5eFQwSEJyMExFYTNtYkV2VXZiLVFkWGJkS3hoelB3?oc=5\" target=\"_blank\">ToolGen sues Vertex in US, expanding CRISPR patent licensing dispute</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">IAM Patent</font>",
      "published": "2025-11-28T13:28:28+00:00",
      "source": "IAM Patent"
    }
  ],
  "product_launches": [
    {
      "title": "Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQd0g4T3hlT04wT2E3VkRHZHk2cFVHQmZOamlLYm9oTE1oeWsyQWVqbHlycDhiS2Vva2ZnRzluYmJuWEJ1TjdubDZDa1JwVmxsMU4yWjlfTzlsazZwV3VQdFgwbkJBakJjUmdRb1lsUGZPbFBCMXZwaEN3SXNfdGFWZ1VKcnpjZWE2c0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxQd0g4T3hlT04wT2E3VkRHZHk2cFVHQmZOamlLYm9oTE1oeWsyQWVqbHlycDhiS2Vva2ZnRzluYmJuWEJ1TjdubDZDa1JwVmxsMU4yWjlfTzlsazZwV3VQdFgwbkJBakJjUmdRb1lsUGZPbFBCMXZwaEN3SXNfdGFWZ1VKcnpjZWE2c0E?oc=5\" target=\"_blank\">Is Vertex Still a Bargain After Latest Pipeline Progress and Five Year 90.6% Gain?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-27T16:12:37+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-28",
      "close": 433.6099853515625
    },
    "history": [
      {
        "date": "2025-11-19",
        "close": 421.0299987792969
      },
      {
        "date": "2025-11-20",
        "close": 422.32000732421875
      },
      {
        "date": "2025-11-21",
        "close": 426.760009765625
      },
      {
        "date": "2025-11-24",
        "close": 424.0
      },
      {
        "date": "2025-11-25",
        "close": 429.82000732421875
      },
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      },
      {
        "date": "2025-11-28",
        "close": 433.6099853515625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}